Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Re Contract

10 Dec 2009 14:27

RNS Number : 9323D
Biofutures International plc
10 December 2009
 



Biofutures International plc

("Biofutures" or the "Company")

Process System Contract

10 December 2009 

Following the announcement on 20 February 2009Biofutures is now pleased to announce that its wholly owned subsidiary, Zurex Corporation Sdn. Bhd. ("Zurex"), has today entered into a contract (the "Contract") with WS Bioengineering Pte. Ltd. ("WS Bio") for the supply of a complete physical refining plant system capable of refining crude palm oil into refined bleached and deodorized palm oil (the "Refining System") for the 200,000 metric tonne per annum palm oil refinery plant (the "Refinery") currently being constructed by WS Bio on the 14 acre site owned by Zurex at POIC Lahad Datu in Sabah, Malaysia.

The fixed value of the Contract is RM7.28 million (approximately £1.3 million at the current exchange rate), of which 30 per cent (the "Initial Payment") is payable within seven (7) days from the date of the Contract and the balance in the form of a full irrevocable and confirmed letter of credit ("LC") in favour of WS Bio, which WS Bio is entitled to present for payment upon presentation by WS Bio of complete shipping documents in respect of the machinery, equipment and items to be supplied by WS Bio as part of the Refining System under the Contract. WS Bio is required to complete the supply of the Refining System within eight (8) months of receipt of the Initial Payment and the LC. 

WS Bio is also the turnkey contractor for the construction and commissioning of the Refinery and the directors of Biofutures consider that the award of the Contract to WS Bio will lead to an effective and coordinated implementation of the entire project.

Yong Khai Weng is a director of both WS Bio and Zurex (although he is not a director of Biofutures) and, accordingly, the Contract represents a related party transaction for the purposes of the AIM Rules. The directors of Biofutures consider, having consulted with Blomfield Corporate Finance Limited, the Company's AIM nominated adviser, that the terms of the Contract are fair and reasonable insofar as the shareholders of the Company are concerned.

Biofutures is also pleased to announce that Zurex has been offered a bank facility by Bank Kerjasama Rakyat Malaysia Bhd., a licensed bank in Malaysia, for the aggregate sum of up to RM47 million (approximately £8.3 million at the current exchange rate) consisting of two tranches, of which RM28.8 million is for capital expenditure and RM18.2 million for working capital. All remaining conditions precedent as imposed by the bank can be met and Biofutures expects to be able to drawdown soon. 

The Board now considers that the refinery plant will not be operational until 30 September 2010, such delay being attributable to the negotiations and commencement of arbitration proceedings with JJ-Lurgi Engineering Sdn Bhd and the time taken to agree the bank facility against the backdrop of the current difficult economic environment.

The total cost to build the refinery plant, including this Contract, is expected to be between RM38 million and RM40 million. This is in addition to the costs that had been incurred prior to the cessation of the biodiesel project.

For further information please contact:

Enquiries:

Julie Pomeroy, Finance Director

Biofutures International plc

Tel: 07747 624 199

Derek Crowhurst

Blomfield Corporate Finance Limited

Tel: 020 7444 0800

Daniel Briggs

Religare Hichens, Harrison plc

Tel: 020 7444 0500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTTMBITMMTBBJL
Date   Source Headline
16th Mar 20187:00 amRNSAcquisition Update and AIM Cancellation
16th Feb 20187:00 amRNSConfirmation of Resignation of Nomad and Broker
31st Jan 20181:47 pmRNSNotice of Resignation of Nomad and Broker
17th Jan 20189:24 amRNSResignation of Director
8th Jan 20182:50 pmRNSProposed Acquisition Update
30th Nov 20177:30 amRNSSuspension - Graphene Nanochem Plc
30th Nov 20177:00 amRNSProposed Acquisition and Suspension of Trading
12th Oct 20174:40 pmRNSSecond Price Monitoring Extn
12th Oct 20174:35 pmRNSPrice Monitoring Extension
11th Oct 20174:40 pmRNSSecond Price Monitoring Extn
11th Oct 20174:35 pmRNSPrice Monitoring Extension
29th Sep 201711:30 amRNSInterim Results
13th Sep 20179:31 amRNSHolding(s) in Company
13th Sep 20179:27 amRNSHolding(s) in Company
11th Sep 201712:07 pmRNSSecond Price Monitoring Extn
11th Sep 201712:02 pmRNSPrice Monitoring Extension
11th Sep 201711:45 amRNSConversion of Loan Notes and Issue of Equity
4th Sep 201710:15 amRNSConversion of loan note and issue of equity
2nd Aug 20171:20 pmRNSConversion of loan note and issue of equity
26th Jul 201711:30 amRNSResult of Annual General Meeting
4th Jul 20179:59 amRNSConversion of loan note and issue of equity
30th Jun 20177:03 amRNSPreliminary Results
27th Jun 20174:35 pmRNSPrice Monitoring Extension
23rd Jun 20174:35 pmRNSPrice Monitoring Extension
13th Jun 20177:00 amRNSPolymer Division Paid Pilot
22nd May 201712:54 pmRNSPlatDrill Deployment In Myanmar
15th May 201712:35 pmRNSIssuance of Tranche 2 Loan Notes
12th Apr 20172:47 pmRNSConversion of loan note and issue of equity
3rd Apr 201711:47 amRNSConversion of Loan Note and Issue of Equity
31st Mar 20179:05 amRNSUpdate on Debt Rationalisation
8th Mar 201712:00 pmRNSConversion of loan note and issue of equity
3rd Mar 20177:00 amRNSCommercial deployment in Turkmenistan
20th Feb 20174:40 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
3rd Feb 20177:00 amRNSConversion of loan note and issue of equity
29th Dec 20164:19 pmRNSFurther information on 2015 report and accounts
28th Dec 20167:00 amRNSContract Win
23rd Dec 201612:35 pmRNSPrice Monitoring Extension
23rd Dec 20168:45 amRNSRestoration - Graphene NanoChem PLC
23rd Dec 20168:15 amRNSIssuance of Loan Notes and Resumption of Trading
6th Dec 20162:44 pmRNSResult of AGM
14th Nov 20165:04 pmRNSInterim Results
14th Nov 20165:01 pmRNSProposed Share Capital Reorganisation
14th Nov 20165:00 pmRNSPreliminary Results
31st Oct 20164:35 pmRNSUpdate on pending 2015 Annual Results
30th Sep 20163:20 pmRNSUpdate on 2015 Annual Results & 2016 Interims
1st Sep 20161:21 pmRNSUpdate on pending 2015 Annual Results
29th Jul 20167:00 amRNSUpdate on pending 2015 Annual Results
29th Jun 20167:30 amRNSSuspension - Graphene Nanochem Plc
29th Jun 20167:30 amRNSStatement re. Suspension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.